Lv1
48 积分 2024-01-11 加入
LncRNA XIST/miR-455-3p/HOXC4 axis promotes breast cancer development by activating TGF-β/SMAD signaling pathway
1个月前
已完结
Genomic somatic alterations of human epidermal growth factor-2 (HER2) gene: A pan-cancer analysis
1个月前
已完结
Impact of HER2 mutation status on personalized molecular targeted therapy in advanced breast cancers
2个月前
已关闭
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
4个月前
已完结
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
4个月前
已完结
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial
4个月前
已完结
HER-2基因突变在乳腺癌中的研究现状
5个月前
已完结
Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer
8个月前
已完结
The landscape of NRG1 fusions based on NGS in Chinese solid tumor patients
8个月前
已完结
P86.11 A Real-World Feasibility Study of Patients with Solid Tumors Harboring NRG1 Gene Fusions: NSCLC Subset Analysis
8个月前
已完结
皖公网安备34019202002308
